Treatment of malignant gliomas with interstitial irradiation and hyperthermia
/in Glioblastoma, Hyperthermia, International Publications /von 1992-01-01 / Int. J. Radiat. Oncol. Biol. Phys. 1992;24(4):657-67[Radiofrequency hyperthermia in malignant brain tumors: clinical trials]
/in Glioblastoma, Hyperthermia, International Publications /von 1988-04-01 / Gan To Kagaku Ryoho 1988 Apr;15(4 Pt 2-2):1370-5[Local hyperthermia of malignant brain tumors]
/in Glioblastoma, Hyperthermia, International Publications /von 1987-05-29 / Wien. Klin. Wochenschr. 1987 May;99(11):393-7Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcoma
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 1984-06-15 / Cancer 1984 Jun;53(12):2585-91Combination radiofrequency hyperthermia and chemotherapy (BCNU) for brain malignancy. Animal experience and two case reports
/in Glioblastoma, Hyperthermia, International Publications /von 1984-01-01 / J. Neurooncol. 1984;2(1):19-28[Effect of whole-body artificial hyperthermia on the immunity function in cancer patients]
/in Gastric Cancer, Hyperthermia, International Publications /von 1984-01-01 / Vopr Onkol 1984;30(5):39-43[Local hyperthermia therapy of malignant brain tumor using radiofrequency. Effects on subcutaneously transplanted experimental brain tumor]
/in Glioblastoma, Hyperthermia, International Publications /von 1982-02-01 / Neurol. Med. Chir. (Tokyo) 1982 Feb;22(2):103-10IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
- Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
- A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma